GRIN THERAPEUTICS A NEURVATI NEUROSCIENCES COMPANY
Live / Allowed — Notice of allowance issued (as of 13 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99126773
- Mark type
- Design + words
- Filed
- 08 Apr 2025
- Published for opposition
- 18 Nov 2025
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and therapeutic preparations for the treatment of pediatric neurodevelopmental disorders
Owner
- GRIN Therapeutics, Inc., New York, NY, US
- GRIN Therapeutics, Inc., New York, NY, US
Prior registrations
Prosecution history
- 25 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Nov 2025 — PUBLISHED FOR OPPOSITION
- 12 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED